Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
CCDC85A-ALK fusion
i
Other names:
NBLST3, CD246, Anaplastic Lymphoma Kinase, Anaplastic Lymphoma Kinase (Ki-1), CD246 Antigen, Mutant Anaplastic Lymphoma Kinase, ALK, ALK Receptor Tyrosine Kinase, Anaplastic Lymphoma Receptor Tyrosine Kinase, ALK Tyrosine Kinase Receptor, CCDC85A, Coiled-Coil Domain Containing 85A, KIAA1912, Coiled-Coil Domain-Containing Protein 85A
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
238
;
114800
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
ALK amplification (3)
ALK amplification (3)
›
Associations
(1)
News
Trials
Filter by
Latest
over1year
Lung adenocarcinoma with an uncommon CCDC85A-ALK fusion responding to alectinib: A case report. (PubMed, J Cell Mol Med)
This is the first report of a lung adenocarcinoma patient harbouring a new uncommon anaplastic lymphocyte kinase fusion that showed a remarkable response to alectinib. NGS aids in selecting treatment in non-small cell lung cancer patients.
over 1 year ago
Journal
|
CCDC85A (Coiled-Coil Domain Containing 85A)
|
ALK fusion • CCDC85A-ALK fusion
|
Alecensa (alectinib)
Share via
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login